In December, the U.S.-based National Academy of Sciences published a report classifying myopia, for the first time, as a ...

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large ...

Paediatric ophthalmologist, Dr Katie Williams, discusses her research exploring factors associated with myopia ...

Sydnexis, Inc. ( a pre-commercial stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

An analysis of data from more than 100 studies and 17,000 children has questioned the effectiveness of myopia management ...

Brianna Rhue, OD, FAAO, discussed novel approaches to myopia management and how they can be implemented into clinical ...

Excessive screen time for more than 4 hours per day may significantly increase the risk of developing myopia Digital Screen Time and Myopia A Systematic Review and Dose-Response Meta-Analysis - (https ...

Shark Tank investor Lori Greiner, in a recent post on her social media, spoke about the perils of 'marketing myopia.